Skip to main content

Table 2 Clinical function scores of the three patient groups 2 years after surgery

From: Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial

 

Switch group

ALD group

Control group

P value

JOA score

92.7 ± 7.1

97.7 ± 2.9

94.8 ± 5.7

N.S.

UCLA activity score

6.5 ± 0.7

6.1 ± 0.6

6.4 ± 1.0

N.S.

HHS

96.8 ± 4.1

98.5 ± 2.0

96.7 ± 4.1

N.S.

Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X